Stay updated on AKST4290 with Aflibercept in nAMD Clinical Trial
Sign up to get notified when there's something new on the AKST4290 with Aflibercept in nAMD Clinical Trial page.

Latest updates to the AKST4290 with Aflibercept in nAMD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment; the old version tag (v3.1.0) was removed.SummaryDifference12%
- Check22 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.3%
- Check36 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, indicating a new release. The Back to Top element was removed.SummaryDifference0.7%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important elements.SummaryDifference0.7%
- Check51 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference16%
- Check65 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12, indicating a revision in the content.SummaryDifference0.3%
Stay in the know with updates to AKST4290 with Aflibercept in nAMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AKST4290 with Aflibercept in nAMD Clinical Trial page.